Latest News - Zoetis
Top Corporates Hub
Zoetis
SDZNY or ZTS: Which Is the Better Value Stock Right Now?
27.08.2025 15:40
SDZNY vs. ZTS: Which Stock Is the Better Value Option?
Zoetis to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
27.08.2025 12:30
PARSIPPANY, N.J., August 27, 2025--Zoetis Inc. (NYSE:ZTS) today announced that a representative from the company will participate in the Morgan Stanley 23rd Annual Global Healthcare Conference on Monday, September 8 at 1:05 p.m. ET.
2 Reasons to Watch ZTS and 1 to Stay Cautious
25.08.2025 04:03
Over the past six months, Zoetis’s shares (currently trading at $156.80) have posted a disappointing 7% loss, well below the S&P 500’s 8.6% gain. This might have investors contemplating their next move.
Does Zoetis Offer Value for Investors After Its Recent Rebound in 2025?
21.08.2025 10:23
If you’re on the fence about Zoetis stock, you’re definitely not alone. As the global leader in animal health, Zoetis is often on radar screens of investors searching for a slice of growth and stability. However, recent price swings have left both the bulls and the bears second-guessing their next move. In just the last month, Zoetis has managed a 6.4% gain, recovering some lost ground after sliding over the past year. The stock is still down nearly 13% over the trailing twelve months,...
[Latest] Global Canine Orthopedics Market Size/Share Worth USD 945.2 Million by 2034 at a 8.6% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
13.08.2025 04:30
[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Canine Orthopedics Market size & share revenue was valued at approximately USD 420.2 Million in 2024 and is expected to reach USD 454.6 Million in 2025 and is expected to reach around USD 945.2 Million by 2034, at a CAGR of 8.6% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are B. Braun Melsungen AG, Movo
ZTS Q2 Deep Dive: Market Questions Librela Outlook Amid Double-Digit Growth in Core Franchises
13.08.2025 04:19
Animal health company Zoetis (NYSE:ZTS) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 4.2% year on year to $2.46 billion. The company expects the full year’s revenue to be around $9.53 billion, close to analysts’ estimates. Its non-GAAP profit of $1.76 per share was 9.2% above analysts’ consensus estimates.
5 Revealing Analyst Questions From Zoetis’s Q2 Earnings Call
13.08.2025 04:02
Zoetis’ second quarter saw revenue and adjusted earnings surpass Wall Street expectations, but the market responded negatively, reflecting skepticism over the company’s performance trajectory. Management highlighted robust operational growth across its Companion Animal and Livestock segments, crediting strong execution in the Simparica and Key Dermatology franchises as major contributors. CEO Kristin Peck emphasized the enduring strength of Zoetis’ diversified portfolio despite competitive press
Got $1,000? 3 Dividend Stocks to Buy and Hold Forever
12.08.2025 09:52
Dip into a beaten-down market sector for deals on some proven winners.
Zoetis Inc. Just Recorded A 5.8% EPS Beat: Here's What Analysts Are Forecasting Next
07.08.2025 10:47
NYSE:ZTS 1 Year Share Price vs Fair Value Explore Zoetis's Fair Values from the Community and select yours Zoetis Inc...
ZTS Q2 Earnings & Revenues Beat Estimates, '25 Outlook Raised
05.08.2025 16:21
Zoetis posts better-than-expected Q2 results with rising sales of pet medicines, boosting its 2025 outlook.
Zoetis Lifts Outlook As Companion Animal Portfolio Offsets Librela Decline
05.08.2025 14:50
Animal health firm Zoetis Inc. (NYSE:ZTS) on Tuesday reported a second-quarter 2025 adjusted earnings per share of $1.76, up from $1.56 a year ago, beating the consensus of $1.61. The company reported sales of $2.50 billion, up 4% year over year, beating the consensus of $2.41 billion. On an organic operational basis, revenue for the second quarter of 2025 increased 8% compared with the second quarter of 2024. Revenue in the U.S. segment was $1.4 billion, up 4% and 7% on an organic operational b
Zoetis Reverses And Dives As Its Arthritis Setback Continues
05.08.2025 14:36
Zoetis stock reversed Tuesday, sinking into the red, despite beating second-quarter expectations as Librela sales continued to flounder.
Stocks See Support from Strong Earnings and Rate Cut Speculation
05.08.2025 13:58
The S&P 500 Index ($SPX ) (SPY ) today is up +0.11%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.24%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.20%. September E-mini S&P futures (ESU25 ) are up +0.15%, and September E-mini Nasdaq futures...
Zoetis (ZTS) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
05.08.2025 13:30
The headline numbers for Zoetis (ZTS) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Zoetis Surges After Crushing Expectations And Raising Its Outlook
05.08.2025 13:01
Zoetis stock surged early Tuesday after the animal-health company beat quarterly forecasts, leading to a guidance hike.
Animal healthcare firm Zoetis raises annual forecast on strong pet product demand
05.08.2025 12:24
Zoetis raised annual forecast and beat second-quarter estimates on Tuesday, driven by strong demand for its medicines and vaccines for pets, sending the animal healthcare company's shares surging about 9% in premarket trading. Analysts remain optimistic about the long-term prospects for the animal health industry, citing a rebound in veterinary clinic visits over the coming years as pet ownership grows and aging animals require chronic care treatments. The New Jersey-based company expects 2025 revenue to be between $9.45 billion and $9.60 billion, compared with its earlier range of $9.43 billion to $9.58 billion.
Zoetis Inc. 2025 Q2 - Results - Earnings Call Presentation
05.08.2025 12:20
The following slide deck was published by Zoetis Inc.
Zoetis Inc. (ZTS) Q2 2025 Earnings Call Transcript
05.08.2025 12:20
Zoetis Inc. (NYSE:ZTS) Q2 2025 Earnings Conference Call August 5, 2025 8:30 AM ETCompany ParticipantsKristin C.
Zoetis (ZTS) Q2 Earnings and Revenues Surpass Estimates
05.08.2025 12:10
Zoetis (ZTS) delivered earnings and revenue surprises of +8.64% and +2.44%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zoetis (NYSE:ZTS) Posts Better-Than-Expected Sales In Q2, Stock Soars
05.08.2025 11:59
Animal health company Zoetis (NYSE:ZTS) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, with sales up 4.2% year on year to $2.46 billion. The company expects the full year’s revenue to be around $9.53 billion, close to analysts’ estimates. Its non-GAAP profit of $1.76 per share was 9.2% above analysts’ consensus estimates.